PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...
The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...
Built on decades of shared AI research and development across the GN Group, GN has pioneered a unique approach to AI that mimics the brain's natural sound processing via a new Intelligent Focus featur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results